Hannah Joseph Hospital
January 22, 2026 – January 27, 2026
| Price | ₹67 - ₹70 |
| GMP Rumors * | ₹0 |
|---|---|
| Lot size | 1500 |
| Issue size | ₹42.00 cr |
| Allotment | Jan 28, 2026 |
| Listing | Jan 30, 2026 |
Hannah Joseph Hospital Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| INDIVIDUAL | 2 | 3000 | 210000 | 665 |
| sHNI | 3 | 4500 | 315000 | 63 |
| bHNI | 10 | 15000 | 1050000 | 127 |
Hannah Joseph Hospital Reservation
| Category | Shares Offered | % |
|---|---|---|
| QIB | 2850000 | 47.5% |
| HNI | 855000 | 14.25% |
| INDIVIDUAL | 1995000 | 33.25% |
| Market Maker | 300000 | 5% |
| Total | 6000000 | 100% |
Hannah Joseph Hospital About
IPO Details
| Total Issue Size | 60,00,000 shares (aggregating up to ₹42 Cr) |
| Fresh Issue | 60,00,000 shares (aggregating up to ₹42 Cr) |
| Face Value | ₹10/- Per Share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 1,66,98,363 shares |
| Share Holding Post Issue | 2,26,98,363 shares |
| Reserved for Market Maker | 3,00,000 shares (aggregating up to ₹2 Cr) |
| Market Maker | Capital Square Financial Services |
Key Performance Indicators (KPI)
| KPI | Sep-25 | Mar-25 | Mar-24 |
|---|---|---|---|
| ROE | 9.39% | 14.77% | 10.13% |
| ROCE | 10.41% | 17.03% | 13.83% |
| EPS (BASIC) | 3.07 | 4.32 | 2.47 |
| P/E Pre IPO | 16.21 | ||
| P/E Post IPO | 15.52 |
Company Financial (In ₹Crore)
| Period Ended | Sep-25 | Mar-25 | Mar-24 | 31Mar-23 |
|---|---|---|---|---|
| Assets | 104.58 | 99.29 | 89.97 | 92.14 |
| Total Income | 42.75 | 77.9 | 63.63 | 54.9 |
| Profit After Tax | 5.12 | 7.21 | 4.07 | 1.01 |
| EBITDA | 11.65 | 20.52 | 17.98 | 16.38 |
| NET Worth | 53.22 | 48.93 | 43.93 | 34.15 |
| Reserves and Surplus | 40.36 | 35.24 | 29.02 | 18.2 |
| Total Borrowing | 31.64 | 33.58 | 31.39 | 42.95 |
About Company
Incorporated in 2011, Hannah Joseph Hospital Limited is a multi-specialty healthcare provider offering quality medical services across key specialties.
Located in Madurai, the hospital operates on a 2-acre campus with central air-conditioning and water heating systems, providing a capacity of 150 beds.
Focuses on delivering quality and affordable healthcare, with strong emphasis on Neurology, Cardiology, Psychiatry, and Trauma Care.
Key departments include:
• Neurosciences – Neurology & Neurosurgery
• Cardio Sciences – Cardiology
• Trauma Care – Orthopaedics, Oral & Maxillofacial Surgery
• Psychiatry – Mental health services
As of November 30, 2025, the hospital employs 364 staff across medical, nursing, and support functions.
IPO proceeds will be utilised for establishing a Radiation Oncology Centre (₹34.98 cr) and general corporate purposes.
Strength
Strong expertise in neurosciences – Established reputation in neurology and neurosurgery services.
Advanced cardiac care capabilities – Well-developed cardiology services supporting critical care needs.
Specialised trauma and orthopaedic care – Integrated trauma management enhances emergency response and outcomes.
Weakness
Radiation oncology execution risk – Delays in equipment procurement, approvals, or commissioning may impact timelines and costs.
Regulatory approval dependency – Failure to obtain or renew statutory licenses for the oncology centre could affect operations.
Project implementation uncertainty – No assurance that the new centre will be completed within the planned schedule or budget.
Hannah Joseph Hospital Lead Manager(s)
Hannah Joseph Hospital Address
Address:134,Lake View Road
K.K. Nagar,
Madurai, Tamil Nadu, 625020
9524729594
E-Mail: cs@hannahjosephhospital.com
Website: https://hannahjosephhospital.com/